Certificate of Analysis and Data Sheet

Catalog No.
HIV-115

Source
E.coli

Description:

Recombinant Human T Lymphotropic Virus fused envelope protein (HTLV-I/II), having a MW of 56kDa.

Purification method:

Recombinant HTLV is purified by proprietary chromatographic technique.

Purity:

Protein is >95% pure as determined by 10% PAGE (coomassie staining) and RP-HPLC.

Protein conc:

1 mg/ml containing 25mM Tris, 250mM Glycine and 0.1% SDS.

Storage:

Recombinant HTLV-I/II is shipped at ambient temperature. Upon arrival, Store at -20⁰C.

Stability :

Five years frozen. One month in solution at room temperature.

Sfecificity:

Immunoreactive with all sera of HTLV-I and HTLV-II infected individuals with antibody response to HTLV envelope.

Applications:

Use as an antigen in ELISA and Western Blots.
Excellent reagent for correct detection of HTLV infections, with minimal specificity problems.

Usage:

This material is offered by ProSpec-TechnoGene for research, laboratory or further evaluation purposes.

Latest Publications:

1. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Cad Saude Publica 2005 May-Jun;21(3):926-31
2. [Prevalence of HTLV-I/II infection among blood donors in Santa Fe Province, Argentina]
Medicina (B Aires) 2004;64(2):125-8
3. Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
J Immunoassay Immunochem 2004;25(3):205-14
4. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Am J Infect Control 2004 Jun;32(4):220-3
5. Seroepidemiology of HTLV-I/II in Argentina: an overview.
J Acquir Immune Defic Syndr 2004 Mar 1;35(3):301-8
6. [Soroprevalence of HTLV-I/II, HIV, siphylis and toxoplasmosis among pregnant women seen at Botucatu - Sao Paulo - Brazil: risk factors for HTLV-I/II infection]
Rev Soc Bras Med Trop 2004 Jan-Feb;37(1):28-32